Copper chelation as a potential treatment for left-ventricular hypertrophy in type 2 diabetes.
Bakker
S J L
SJ
Navis
G
G
Gans
R O B
RO
D000328:Adult; D000368:Aged; D002614:Chelating Agents / Q000627:therapeutic use*; D003300:Copper / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003925:Diabetic Angiopathies / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged
D002614:Chelating Agents; D003300:Copper
Brain Res Rev. 2007 Apr;54(1):19-33
17270275
Eur J Haematol. 2008 Jun;80(6):523-31
18284630
Diabetologia. 2009 Apr;52(4):715-22
19172243